Cantel Medical Corp. (NYSE: CMN) is buying PuriCore International Ltd. for about $27 million.

PuriCore International, a subsidiary of Stafford, England-based PuriCore plc (LSE: PURI), provides maintenance and other services for endoscopes, including automated endoscope re-processors, storage cabinets and other products.

Cantel, headquartered in Little Falls, New Jersey, provides infection prevention products and services for patients, caregivers and other health care providers. The company's products include medical device reprocessing systems, advanced water purification equipment, disinfectants and sterility monitoring products.

The deal will allow Cantel to expand its reach into international markets in England and continental Europe.

In another recent health care services deal, Arsenal Capital Partners, in April, purchased Synchrongenix, which provides services to pharmaceutical and medical device companies. 


Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.